Int. J. Cancer

DOI Crossref

Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns

Ugalde‐Morales E, Grassmann F, Humphreys K, ..., Hall P, Czene K

Int. J. Cancer - (-) - [2020-09-05; online 2020-09-05]

Bioinformatics Support and Infrastructure [Service] Bioinformatics Support, Infrastructure and Training [Service]

DOI Crossref

Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia

Papakonstantinou N, Ntoufa S, Tsagiopoulou M, ..., Rosenquist R, Stamatopoulos K

Int. J. Cancer - (-) - [2018-11-16; online 2018-11-16]

NGI Uppsala (SNP&SEQ Technology Platform) [Service] National Genomics Infrastructure [Service]

PubMed DOI Crossref

Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.

La Fleur L, Boura VF, Alexeyenko A, ..., Karlsson MCI, Botling J

Int. J. Cancer - (-) - [2018-04-18; online 2018-04-18]

Bioinformatics Compute and Storage [Service] Bioinformatics Support and Infrastructure [Service] Bioinformatics Support, Infrastructure and Training [Service] Clinical Genomics Uppsala [Collaborative] NGI Stockholm (Genomics Applications) [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service]

PubMed DOI Crossref

A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival.

Gremel G, Liew M, Hamzei F, ..., Pontén F, Carlson JW

Int. J. Cancer 136 (7) 1608-1618 [2015-04-01; online 2014-08-19]

Tissue Profiling

PubMed DOI Crossref

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.

Micke P, Mattsson JS, Edlund K, ..., Sahin U, Türeci O

Int. J. Cancer 135 (9) 2206-2214 [2014-11-01; online 2014-04-09]

Tissue Profiling

PubMed DOI Crossref

Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.

Cajuso T, Hänninen UA, Kondelin J, ..., Kilpivaara O, Vahteristo P

Int. J. Cancer 135 (3) 611-623 [2014-08-01; online 2014-01-03]

Karolinska High Throughput Center (KHTC)

PubMed DOI Crossref

A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.

Elsir T, Edqvist PH, Carlson J, ..., Nistér M, Smits A

Int. J. Cancer 134 (5) 1123-1131 [2014-03-01; online 2013-09-17]

Tissue Profiling

PubMed DOI Crossref

Novel signatures of cancer-associated fibroblasts.

Bozóky B, Savchenko A, Csermely P, ..., Székely L, Klein G

Int. J. Cancer 133 (2) 286-293 [2013-07-15; online 2013-01-16]

Tissue Profiling

PubMed DOI Crossref

CD99 is a novel prognostic stromal marker in non-small cell lung cancer.

Edlund K, Lindskog C, Saito A, ..., Ostman A, Micke P

GEO

Int. J. Cancer 131 (10) 2264-2273 [2012-11-15; online 2012-03-07]

Array and Analysis Facility Tissue Profiling

PubMed DOI Crossref

Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility.

Castro FA, Ivansson EL, Schmitt M, ..., Gyllensten UB, Pawlita M

pmc mid

Int. J. Cancer 130 (2) 349-355 [2012-01-15; online 2011-03-10]

NGI Uppsala (Uppsala Genome Center) National Genomics Infrastructure